Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldurazyme in Lactating Women with MPS I
NCT00418821Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Oct 2010
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of laronidase in mucopolysaccharidosis type I, sponsored by Sanofi. Primary endpoints: Number of Lactating Women With Serum IgG Antibodies to Laronidase at 18 months, Amount of IgG Antibody Titers to Laronidase in Lactating Women at Week 12 and 29 more. Started Oct 2010; status: terminated.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on NCT00418821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418821.